These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

821 related articles for article (PubMed ID: 18268193)

  • 1. Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis.
    Chowdhury SA; Lin J; Sadiq SA
    Arch Neurol; 2008 Feb; 65(2):232-5. PubMed ID: 18268193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis.
    Rentzos M; Cambouri C; Rombos A; Nikolaou C; Anagnostouli M; Tsoutsou A; Dimitrakopoulos A; Triantafyllou N; Vassilopoulos D
    J Neurol Sci; 2006 Feb; 241(1-2):25-9. PubMed ID: 16316662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients.
    Lebrun C; Bensa C; Debouverie M; Wiertlevski S; Brassat D; de Seze J; Rumbach L; Pelletier J; Labauge P; Brochet B; Tourbah A; Clavelou P;
    Arch Neurol; 2009 Jul; 66(7):841-6. PubMed ID: 19597085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excitatory amino acids and multiple sclerosis: evidence from cerebrospinal fluid.
    Sarchielli P; Greco L; Floridi A; Floridi A; Gallai V
    Arch Neurol; 2003 Aug; 60(8):1082-8. PubMed ID: 12925363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide as an activity marker in multiple sclerosis.
    Acar G; Idiman F; Idiman E; Kirkali G; Cakmakçi H; Ozakbaş S
    J Neurol; 2003 May; 250(5):588-92. PubMed ID: 12736739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness.
    Link H; Huang YM
    J Neuroimmunol; 2006 Nov; 180(1-2):17-28. PubMed ID: 16945427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients.
    Sarchielli P; Di Filippo M; Ercolani MV; Chiasserini D; Mattioni A; Bonucci M; Tenaglia S; Eusebi P; Calabresi P
    Neurosci Lett; 2008 Apr; 435(3):223-8. PubMed ID: 18353554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of angiotensin II in the cerebrospinal fluid of patients with multiple sclerosis.
    Kawajiri M; Mogi M; Osoegawa M; Matsuoka T; Tsukuda K; Kohara K; Horiuchi M; Miki T; Kira JI
    Mult Scler; 2008 May; 14(4):557-60. PubMed ID: 18562510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis.
    Minneboo A; Barkhof F; Polman CH; Uitdehaag BM; Knol DL; Castelijns JA
    Arch Neurol; 2004 Feb; 61(2):217-21. PubMed ID: 14967769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble adhesion molecules (sVCAM-1 and sICAM-1) in cerebrospinal fluid and serum correlate with MRI activity in multiple sclerosis.
    Rieckmann P; Altenhofen B; Riegel A; Baudewig J; Felgenhauer K
    Ann Neurol; 1997 Mar; 41(3):326-33. PubMed ID: 9066353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of clinical features and findings on cranial magnetic resonance imaging with urinary myelin basic protein-like material in patients with multiple sclerosis.
    Whitaker JN; Williams PH; Layton BA; McFarland HF; Stone LA; Smith ME; Kachelhofer RD; Bradley EL; Burgard S; Zhao G
    Ann Neurol; 1994 May; 35(5):577-85. PubMed ID: 7513981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid levels of iodothyronines and nerve growth factor in patients with multiple sclerosis and neuromyelitis optica.
    Jiang Y; Yang Y; Zhang B; Peng F; Bao J; Hu X
    Neuro Endocrinol Lett; 2009 Mar; 30(1):85-90. PubMed ID: 19300400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased levels of IL-23 and osteopontin in serum and cerebrospinal fluid of multiple sclerosis patients.
    Wen SR; Liu GJ; Feng RN; Gong FC; Zhong H; Duan SR; Bi S
    J Neuroimmunol; 2012 Mar; 244(1-2):94-6. PubMed ID: 22329905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calprotectin levels in the cerebrospinal fluid reflect disease activity in multiple sclerosis.
    Berg-Hansen P; Vandvik B; Fagerhol M; Holmøy T
    J Neuroimmunol; 2009 Nov; 216(1-2):98-102. PubMed ID: 19800696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis.
    Sharief MK; Hentges R
    N Engl J Med; 1991 Aug; 325(7):467-72. PubMed ID: 1852181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI as an outcome in multiple sclerosis clinical trials.
    Daumer M; Neuhaus A; Morrissey S; Hintzen R; Ebers GC
    Neurology; 2009 Feb; 72(8):705-11. PubMed ID: 19073945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid total tau protein levels in patients with multiple sclerosis.
    Terzi M; Birinci A; Cetinkaya E; Onar MK
    Acta Neurol Scand; 2007 May; 115(5):325-30. PubMed ID: 17489943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of outcome predictors in first-episode acute myelitis: a retrospective study of 53 cases.
    Gajofatto A; Monaco S; Fiorini M; Zanusso G; Vedovello M; Rossi F; Turatti M; Benedetti MD
    Arch Neurol; 2010 Jun; 67(6):724-30. PubMed ID: 20558391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon inhibitory activity in patients with multiple sclerosis.
    Chadha K; Weinstock-Guttman B; Zivadinov R; Bhasi K; Muhitch J; Feichter J; Tamaño-Blanco M; Abdelrahman N; Ambrus J; Munschauer F; Ramanathan M
    Arch Neurol; 2006 Nov; 63(11):1579-84. PubMed ID: 17101826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating biomarkers of neuronal degeneration and neuroinflammation in CSF of patients with multiple sclerosis-osteopontin as a potential marker of clinical severity.
    Szalardy L; Zadori D; Simu M; Bencsik K; Vecsei L; Klivenyi P
    J Neurol Sci; 2013 Aug; 331(1-2):38-42. PubMed ID: 23706476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.